ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2022
Safety and Efficacy of GLP-1 Receptor Agonists and SGLT2 Inhibitors Among Veterans With Type 2 Diabetes.
Lauren McCulley et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.